Abstract:
Objective
To explore the efficacy of endoscopic retrograde cholangiopancreatography(ERCP) and laparoscopic choledocholithotomy (LCBDE) in the treatment of acute severe cholangitis (ACST)secondary to choledocholithiasis.
Methods
The clinical data of one hundred and twenty patients with ACST secondary to CBDS who received surgical treatment were retrospectively analyzed from January 2022 to January 2024.AccorThe clinical data of 120 patients with ACST secondary to choledocholithiasis who underwent surgical treatment from January 2022 to January 2024 were retrospectively analyzed.According to different surgical methods, patients receiving ERCP treatment were assigned to the ERCP group (n=68 cases) and those receiving LCBDE treatment were assigned to the LCBDE group (n=52 cases).SPSS 26.0 was used for data processing.Measurement data such as perioperative indicators were expressed as (x± s), and independent sample t test was performed.The incidence of complications and other statistical data were χ2 test.Test level α=0.05.
Results
The amount of intraoperative blood loss in ERCP group was lower than that in LCBDE group, and the operation time, activity recovery time, first exhaust time and hospital stay were shorter than that in LCBDE group(P<0.05).There was no significant difference in stone removal rate between ERCP group and LCBDE group(98.5% vs.96.2%, P>0.05).The liver and bile biochemical indexes of serum total bilirubin (TBIL), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in ERCP group and LCBDE group were lower than those before surgery (P<0.05), but there was no statistical significance between the two groups (P>0.05).The inflammatory markers of white blood cell count (WBC), neutrophil count (ANC) and serum high mobility group protein B1 (HMGB1) in 2 groups were lower than those before surgery (P<0.05), and ERCP group was significantly lower than LCBDE group (P<0.05).The overall complication rate in the ERCP group was lower than that in the LCBDE group (1.5% vs.11.5%) (P<0.05).
Conclusion
ERCP is more effective than LCBDE in the treatment of ACST secondary to choledocholithiasis.This procedure can significantly improve the surgical and postoperative recovery indicators of patients, promote the rapid recovery of liver and gallbladder and inflammation, and the risk of complications is small, so it can be used as the first choice in clinical treatment of ACST secondary to choledocholithiasis.
Key words:
Secondary Acute Severe Cholangitis,
Cholangiopancreatography, Endoscopic Retrograde,
Laparoscopic Common Bile Duct Exploration
Bo Li, Pengbo Jia, Dong Li, Xiaoqing Li. Effect of ERCP and LCBDE on acute severe cholangitis secondary to choledocholithiasis[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 60-63.